PHBI
Pharmagreen Biotech Inc. [PHBI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PHBI Stock Summary
Top PHBI Correlated Resources
PHBI
Top 10 Correlated ETFs
PHBI
Top 10 Correlated Stocks
PHBI
In the News
PHBI Financial details
Company Rating
-
Market Cap
564.1K
Income
-690.69K
Revenue
4.23K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-1.04
Forward P/E
-
PEG
0.83
P/S
212.16
P/B
-0.14
P/C
-
P/FCF
-2.39
Quick Ratio
-
Current Ratio
0.02
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-14.05%
EPS Q/Q
-50%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-202%
ROE
15%
ROC
0.2%
Gross Margin
12%
Oper. Margin
-25981%
Profit Margin
-18141%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.0E-4-0.006
52W High
-
52W Low
-
RSI
34.05
Rel Volume
0.09
Avg Volume
1.99M
Volume
182K
Perf Week
-15.38%
Perf Month
-55.1%
Perf Quarter
-21.43%
Perf Half Y
-8.33%
-
-
-
-
Beta
1.547
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0011
Change
-8.33%
Company Profile
- Volume Average 1.99M
- Market Capitalization 564.1K
- CEO Mr. Peter Wojcik B.A.
- Headquarters Coquitlam,BC,CA
- IPO Date 2018-08-15
-
Website
https://www.pharmagreen.ca 
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.
